Ovarian cancer with pleural and lung metastasis in Dr. Soetomo Hospital, Surabaya, Indonesia, in 2014-2015
Downloads
Objectives: To know the characteristics of ovarian cancer patients with pleural and lung metastasis, and survival rates of ovarian cancer patients with pleural and lung metastasis in Dr. Soetomo Hospital Surabaya in 2014-2015.
Materials & Methods: This was a descriptive observational study using secondary data from medical records in dr. Soetomo Hospital, Surabaya, Indonesia, in 2014 and 2015
Results: Number of new patients of ovarian cancer in dr. Soe-tomo, Hospital, Surabaya in 2014 was 170 patients (14%) and 122 patients (12%) in 2015. Ovarian cancer patients most often came at the stage IIIC (33.38%) with the most histopathological type was epithelial ovarian cancer. There were 5 patients with ovarian cancer with pleural metastasis and 7 patients with lung metastasis. Pleural metastasis was 80% diagnosed at the time of ovarian cancer's diagnosis, whereas 57.15% of lung metastasis were diag-nosed >12 months after the ovarian cancer's diagnosis. Pleural metastasis was established by pleural fluid cytology, while lung metastasis with radiological features and/or biopsies. The most common feature of lung metastasis was nodal (71.42%). Ascites was found in 80% of ovarian cancer with pleural metastasis, but only 42.86% in lung metastasis. In 2 patients receiving NAC chemotherapy and continued by interval debulking, both had negative residues. Median survival rate in ovarian cancer with pleural metastasis was 7 months, whereas in lung metastasis was 12 months.
Conclusions: Number of new patients of ovarian cancer in 2014-2015 in dr. Soetomo Hospital was on rising and was the second largest number of visits after cervical cancer. In 2014-2015, there were 5 patients with ovarian cancer and pleural metastasis and 7 patients with ovarian cancer patients and lung metastasis. Median survival rate in ovarian cancer with pleural metastasis was 7 months, whereas in lung metastasis it was 12 months.
Novak E. Berek & Novak's gynecology. Lippincott Williams & Wilkins; 2007.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015 Mar 1;136(5).
Kemenkes. Hari Kanker Sedunia. Jakarta : Pusat Data dan Informasi Kementrian Kesehatan RI ; 2015
Cormio G, Rossi C, Cazzolla A, Resta L, Loverro G, Greco P, Selvaggi L. Distant metastases in ovarian carcinoma. International Journal of Gynecological Cancer. 2003 Mar 1;13(2):125-9.
Rose PG, Piver MS, Tsukada Y, Lau T. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer. 1989 Oct 1;64(7):1508-13.
Fidler IJ. The pathogenesis of cancer metastasis: the'seed and soil'hypothesis revisited. Nature Reviews Cancer. 2003 Jun 1;3(6):453-9.
Bacac M, Stamenkovic I. Metastatic cancer cell. Annu. Rev. pathmechdis. Mech. Dis.. 2008 Feb 28;3:221-47.
Hsia, D., & Musani, A. Management of Malignant Pleural Effusions. Turner White Communications, Inc ; 2014.
Travis WD, Brambilia E, Muller-Hermelink HK, & Harris C. Tumor of The Lung. Lyon- France: IARC; 2004.
Seo JB, Im JG, Goo JM, Chung MJ, Kim MY. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 2001 Mar;21(2):403-17.
Doufekas K, Olaitan A. Clinical epidemiology of epithelial ovarian cancer in the UK. International journal of women's health. 2014;6:537.
Wikborn C, Pettersson F, Moberg PJ. Delay in diagnosis of epithelial ovarian cancer. International Journal of Gynecology & Obstetrics. 1996 Mar 1;52(3):263-7.
Rauh-Hain JA, Krivak TC, del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Reviews in obstetrics and gynecology. 2011;4(1):15.
Pepin K, del Carmen M, Brown A, Dizon DS. CA 125 and Epithelial Ovarian Cancer: Role in Screening, Diagnosis, and Surveillance. American Journal of Hematology/Oncology®. 2014 Dec 1;10(6).
van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, Pavlik EJ, Kryscio RJ. Ovarian cancer screening with annual transvaginal sonography. Cancer. 2007 May 1;109(9):1887-96.
Kerr VE, Cadman ED. Pulmonary metastases in ovarian cancer analysis of 357 patients. Cancer. 1985 Sep 1;56(5):1209-13.
BeÅ¡ević J, Gunter MJ, Fortner RT, Tsilidis KK, Weiderpass E, Onland-Moret NC, Dossus L, Tjí¸nneland A, Hansen L, Overvad K, Mesrine S. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study. British journal of cancer. 2015 Dec 1;113(11):1622.
Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006 Apr 1;73(7):1211-20.
The American Thoracic Society. Management of Malignant Pleural Effusions. Am J Respir Crit Care Med. 2000.
Berek JS, Crum C, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. International Journal of Gynecology & Obstetrics. 2015 Oct 1;131(S2).
Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecologic oncology. 2011 Sep 30;122(3):536-40.
Ulker V, Kuru O, Numanoglu C, Akbayır O, Polat I, Uhri M. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience. Archives of gynecology and obstetrics. 2014 May 1;289(5):1087-92.
Zarogoulidis K, Zarogoulidis P, Darwiche K, Tsakiridis K, Machairiotis N, Kougioumtzi I, Courcoutsakis N, Terzi E, Zaric B, Huang H, Freitag L. Malignant pleural effusion and algorithm management. Journal of thoracic disease. 2013 Sep;5(Suppl 4):S413.
Seo JB, Im JG, Goo JM, Chung MJ, Kim MY. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 2001 Mar;21(2):403-17.
Winokur RS, Pua BB, Sullivan BW, Madoff DC. Percutaneous lung biopsy: technique, efficacy, and complications. InSeminars in interventional radiology 2013 Jun (Vol. 30, No. 02, pp. 121-127). Thieme Medical Publishers.
Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Archiv. 2012 Mar 1;460(3):237-49.
Jenison EL, Montag AG, Griffiths CT, Welch WR, Lavin PT, Greer J, Knapp RC. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecologic oncology. 1989 Jan 1;32(1):65-71.
Macrí¬ A. New approach to peritoneal surface malignancies. World journal of gastrointestinal oncology. 2010 Jan 15;2(1):9.
Kitai T. Pulmonary metastasis from pseudomyxoma peritonei. Gastroenterology research and practice. 2012 Jul 12;2012.
Sood AK, Sorosky JI, Dolan M, Anderson B, Buller RE. Distant metastases in ovarian cancer: association with p53 mutations. Clinical Cancer Research. 1999 Sep 1;5(9):2485-90.
Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. The lancet oncology. 2006 Nov 30;7(11):925-34.
Smolle E, Taucher V, Haybaeck J. Malignant ascites in ovarian cancer and the role of targeted therapeutics. Anticancer research. 2014 Apr 1;34(4):1553-61.
Rosen B, Laframboise S, Ferguson S, Dodge J, Bernardini M, Murphy J, Segev Y, Sun P, Narod SA. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer. Gynecologic oncology. 2014 Sep 30;134(3):462-7.
Gill SE, McGree ME, Weaver AL, Cliby WA, Langstraat CL. Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection. Gynecologic oncology. 2017 Feb 28;144(2):266-73.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
